SCHEMBL15025142

SCHEMBL15025142

NN1CCC(c2ccccn2)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.49
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
SPR P35270 1/20 0.44
MAP4K4 O95819 1/20 0.43
USP30 Q70CQ3 1/20 0.43
DRD4 P21917 6/20 0.43
KDM5A P29375 1/20 0.43
DRD2 P14416 3/20 0.40
PDCD1LG2 Q9BQ51 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120829 0.89 DRD4 (0.48) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL19087063 0.79 HSD11B1 (0.46) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL2076284 0.79 HSD11B1 (0.46) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL2076700 0.79 HSD11B1 (0.46) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL21274017 0.77 DRD4 (0.50) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL3845634 0.77 DRD4 (0.50) HSD11B1DRD4DRD2PDCD1LG2CD274
SCHEMBL19117549 0.77 DRD4 (0.50) HSD11B1DRD4DRD2PDCD1LG2CD274
SCHEMBL29640084 0.76 HSD11B1 (0.59) HSD11B1SPRMAP4K4USP30DRD4
SCHEMBL3104655 0.76 USP30 (0.52) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL2737376 0.76 KDM5A (0.48) HSD11B1CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788333-B1 1,2,4-TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INT (DE) 2016-03-23 EP disclosed
WO-2013083741-A1 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 WO disclosed